Does anyone know of a drug currently on the market
Post# of 72440
If not, and Novartis is still in development mode of it from 2018, then I take that to mean it hasn't been fully validated yet so IPIX should be given a price break for being a pioneer in forwarding BDD technology.
My point of view only.
Sorry for calling BDD by the wrong initials (IBB) in prior post of mine.